These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6945605)

  • 1. Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
    Sahai S; Arora RC; Meltzer HY
    Psychiatry Res; 1981 Oct; 5(2):111-4. PubMed ID: 6945605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between MAO activity in blood platelets obtained by single and multiple centrifugations.
    Arora RC; Sahai S; Meltzer HY
    Psychiatry Res; 1983 Feb; 8(2):147-51. PubMed ID: 6574532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase. I: Effect of temperature, anticoagulant, and centrifugation technique.
    Sahai S; Arora RC; Meltzer HY
    Biol Psychiatry; 1981 Nov; 16(11):1077-83. PubMed ID: 6819006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase and plasma amine oxidase: effect of anticoagulant and centrifugation technique on platelet yield and enzyme activity.
    Baron M; Levitt M; Gruen R
    Neuropsychobiology; 1983; 9(1):9-12. PubMed ID: 6412154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase activity in different density gradient fractions of human platelets.
    Murphy DL; Costa JL; Shafer B; Corash L
    Psychopharmacology (Berl); 1978 Oct; 59(2):193-7. PubMed ID: 103122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase in schizophrenia.
    Belmaker RH; Reches A; Ebstein RP
    Lancet; 1977 Oct; 2(8042):821. PubMed ID: 71627
    [No Abstract]   [Full Text] [Related]  

  • 14. Tranylcypromine lowers human platelet MAO B activity but not concentration.
    Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
    Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
    Filinger EJ
    Gen Pharmacol; 1989; 20(6):821-2. PubMed ID: 2591711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase as a function of nongenetic factors.
    Friedhoff AJ; Miller JC
    Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of platelet monoamine oxidase in whole blood.
    van Kempen GM; van Brussel JL; Pennings EJ
    Clin Chim Acta; 1985 Dec; 153(3):197-202. PubMed ID: 4075526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.